HomeCompareOCUP vs CL

OCUP vs CL: Dividend Comparison 2026

OCUP yields 170.94% · CL yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCUP wins by $49.53M in total portfolio value
10 years
OCUP
OCUP
● Live price
170.94%
Share price
$1.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.57M
Annual income
$23,046,519.63
Full OCUP calculator →
CL
CL
● Live price
2.44%
Share price
$85.23
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.0K
Annual income
$5,451.69
Full CL calculator →

Portfolio growth — OCUP vs CL

📍 OCUP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCUPCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCUP + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCUP pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCUP
Annual income on $10K today (after 15% tax)
$14,529.91/yr
After 10yr DRIP, annual income (after tax)
$19,589,541.69/yr
CL
Annual income on $10K today (after 15% tax)
$207.44/yr
After 10yr DRIP, annual income (after tax)
$4,633.94/yr
At 15% tax rate, OCUP beats the other by $19,584,907.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCUP + CL for your $10,000?

OCUP: 50%CL: 50%
100% CL50/50100% OCUP
Portfolio after 10yr
$24.80M
Annual income
$11,525,985.66/yr
Blended yield
46.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

OCUP
No analyst data
Altman Z
-6.1
Piotroski
3/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+8.5% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCUP buys
0
CL buys
0
No recent congressional trades found for OCUP or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCUPCL
Forward yield170.94%2.44%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$49.57M$41.0K
Annual income after 10y$23,046,519.63$5,451.69
Total dividends collected$46.28M$18.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: OCUP vs CL ($10,000, DRIP)

YearOCUP PortfolioOCUP Income/yrCL PortfolioCL Income/yrGap
1← crossover$27,794$17,094.02$11,014$313.84+$16.8KOCUP
2$74,143$44,402.93$12,200$415.44+$61.9KOCUP
3$190,032$110,699.08$13,607$553.09+$176.4KOCUP
4$468,500$265,166.46$15,301$741.41+$453.2KOCUP
5$1,112,264$610,968.56$17,374$1,002.00+$1.09MOCUP
6$2,545,727$1,355,604.69$19,958$1,367.44+$2.53MOCUP
7$5,623,629$2,899,701.52$23,243$1,887.87+$5.60MOCUP
8$12,003,803$5,986,519.26$27,512$2,642.43+$11.98MOCUP
9$24,786,500$11,942,431.58$33,197$3,759.22+$24.75MOCUP
10$49,568,075$23,046,519.63$40,973$5,451.69+$49.53MOCUP

OCUP vs CL: Complete Analysis 2026

OCUPStock

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.

Full OCUP Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this OCUP vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCUP vs SCHDOCUP vs JEPIOCUP vs OOCUP vs KOOCUP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.